Dossier · QRVO · Dormant
QRVO · Qorvo, Inc. · Stock research
Last analysed ·
Current thesis
Merger spread, not a story: SWKS collapsed ~25% on Apple iPhone content loss, dragging implied deal value ($32.50 + 0.960 SWKS) from ~$102 to ~$87.7 while QRVO sits $85.50 under 3% left for underwriting a China SAMR Phase II review with no deadline, against a ~$75-78 break floor.
Invalidation trigger
A weekly close below $80 breaks the post-deal consolidation shelf and prices a materially higher probability of a SAMR rejection or Skyworks walk rather than a timing delay; secondary confirmation if the 2026-07-28 SWKS print cuts FY27 Apple content guidance further and drops implied deal value under $85.
Thesis status
Open commitment catalyst in 9dscored if the trigger above fires How this is scored →Latest analysis and events for QRVO —
As of 2026-07-19, orbyd's latest analysis for Qorvo, Inc. (QRVO): Merger spread, not a story: SWKS collapsed ~25% on Apple iPhone content loss, dragging implied deal value ($32.50 + 0.960 SWKS) from ~$102 to ~$87.7 while QRVO sits $85.50 under 3% left for underwriting a China SAMR Phase II review with no deadline, against a ~$75-78 break floor.
Invalidation trigger: A weekly close below $80 breaks the post-deal consolidation shelf and prices a materially higher probability of a SAMR rejection or Skyworks walk rather than a timing delay; secondary confirmation if the 2026-07-28 SWKS print cuts FY27 Apple content guidance further and drops implied deal value under $85.
Next dated event on file: — catalyst in 9d.
Current Thesis
Qorvo has not traded as a standalone equity since 2025-10-27, when Skyworks agreed to acquire it for $32.50 in cash plus 0.960 Skyworks shares. What changed in the last three weeks is the exchange leg: SWKS fell roughly 25% over 30 days into the $57–58 area on confirmation that Apple is dual-sourcing a key RF component for the next iPhone, cutting Skyworks content ~20–25% and over $380M of mobile revenue. That collapse pulled the deal's implied value down from ~$102 in late June to about $87.7 (32.50 + 0.960 × 57.51), while QRVO only fell to $85.50 (2026-07-17). The gross spread compressed from ~9% to under 3% the ceiling came down to meet the price rather than the price rallying toward the ceiling. Consensus median target sits at $91.46 across 11 analysts (2026-07-16), essentially the deal value plus a hope premium. The remaining reward for underwriting China's SAMR review is now a few percent; the punishment for a break is a gap toward the $75–78 standalone zone. That is not a momentum setup, and the arithmetic no longer pays for the swing risk.
Bullish and bearish views on Qorvo, Inc.
The model's bull view on Qorvo, Inc. (QRVO), in brief: Deal risk is now mostly regulatory, not shareholder. The bear view: The acquirer's earnings power was just structurally impaired. Both cases follow in full.
Bull Case
- Deal risk is now mostly regulatory, not shareholder. Both votes cleared 2026-02-11; the Skyworks issuance passed 120,980,973 for vs 289,580 against. Taiwan's TFTC approved 2026-05-13.
- SAMR is in Phase II with constructive dialogue reported, and both firms have largely vacated the domestic China RF market the structural argument that clearance leaves room for local suppliers such as Maxscend remains the base case among deal desks.
- Management pulled the close date forward. Formal guidance is early calendar 2027, but the May 2026 Form 425 language moved to "increasingly hopeful" about a late-2026 completion.
- The cash component is a larger share of the package after the SWKS derating. At $87.7 implied value, the $32.50 cash leg is ~37% of consideration versus ~32% in late June the equity beta per QRVO share is proportionally lower.
- Financing is arranged. Skyworks ran debt-exchange offers in May 2026 (up to $850M of 2029 notes and $700M of 2031 notes for QRVO paper), with a $500M+ annual synergy target against a ~$22B combined entity.
- The standalone business is not the problem. Q4 FY26 (2026-05-05): adjusted EPS $1.69 vs $1.21 expected, revenue $808.3M vs $800.6M. The prior FY27 framework implied EPS near $7.00 against $6.60 consensus.
Bear Case
- The acquirer's earnings power was just structurally impaired. Apple dual-sourcing is a permanent content loss, not a timing slip. B. Riley cut to Neutral with a $65 target, Stifel to Hold at $62, Mizuho to Neutral at $62; Morningstar took fair value from $95 to $70. Every dollar of SWKS derating removes $0.96 of QRVO deal value by construction.
- The spread no longer compensates for the gate. ~2.6% gross to a close that could land in late 2026 or slip to early 2027 is single-digit annualized against a binary China review with no statutory decision deadline.
- Downside gap is larger than the remaining upside. A SAMR rejection or a Skyworks walk re-rates QRVO toward standalone $75–78 (52-week low $74.93) roughly −10% against +2.6% of arb carry.
- Deal-break risk is no longer purely regulatory. A 25% drawdown in the acquirer's stock changes the internal arithmetic of an equity-heavy deal; SWKS holders bought 0.960-per-share dilution on a mobile revenue base that has since shrunk.
- No information flow from the company. Qorvo has discontinued conference calls and forward guidance for the duration of the transaction. The 2026-07-28 print is a data drop with no management commentary and no path for a positive surprise to re-rate the multiple.
- The quote is pinned, then hostage. QRVO cannot exceed deal value while the merger is live, so the only realistic paths are a slow drift to $87.7 or a gap lower.
Setup & Price Structure
The chart is a spread, and momentum reads on it are artifacts of the acquirer. QRVO printed $93.88 in late June and $85.50 on 2026-07-17 an ~9% decline that tracks the SWKS collapse almost mechanically rather than any QRVO-specific news. The 52-week range is $74.93–$109.49, with price now in the lower third and sitting only ~$2 — above the top of the estimated standalone value band. What used to be a wide arb cushion between market price and break-value has largely closed: the market is paying roughly standalone value plus a thin option on completion. Support is conceptual rather than technical the $80 area is where a spread this tight would imply the market handicapping a genuine break, and $75 is the prior low. Resistance is arithmetic: $32.50 + 0.960 × SWKS, currently $87.7, and it falls every time Skyworks does. Any RSI, 52-week-high, or clustered-price-target signal on this ticker is imported from the acquirer's tape and should not be read as a Qorvo narrative.
Catalyst Calendar (next 30 days)
- 2026-07-28 Qorvo fiscal Q1 FY2027 results, ~4:00pm ET. No conference call, no guidance (both discontinued for the pending transaction). Numbers only.
- 2026-07-28 Skyworks fiscal Q3 FY2026 results, with consensus modelling roughly a 38% year-over-year EPS decline. This is the more consequential print of the two, since ~63% of QRVO's consideration is SWKS equity and the Apple content guidance for FY27 gets refreshed here.
- Undated, any session China SAMR Phase II decision or extension. No posted deadline; the outcome arrives as a headline, not on a calendar.
- ~Late August 2026 (est.) next scheduled Form 425 / proxy supplement window for updated close-timing language.
What Would Change Our Mind
- at which point the question is whether one wants to own an Apple-content-losing RF business at $58, not whether the arb worked.
- A weekly close below $80. That would put the market at a >9% discount to a deal value that has already fallen, signalling a meaningfully higher probability of a break rather than a timing delay.
- Skyworks stabilising above $65 on a credible non-Apple revenue path broad markets, automotive, or edge-IoT replacing lost handset content would lift implied deal value back above $94 and restore an arb worth underwriting.
- Termination, MAC assertion, or renegotiated terms. Any of these makes QRVO a standalone semis story again on FY27 numbers near $7.00 EPS, and it would then deserve a fresh look on its own tape rather than as a spread.
- A SAMR remedy package with divestitures. Conditional approval that carves out material revenue would cut synergy value and likely trade poorly in both names despite technically being a clearance.
Correlation Notes
- Effectively a levered SWKS position with a cash cushion. Beta to Skyworks is 0.960 shares per QRVO share, roughly 63% of consideration at current prices. QRVO cannot decouple upward while the deal is live.
- Apple supply-chain factor exposure. The July derating was an Apple sourcing decision, so QRVO now carries second-hand iPhone build and content risk it does not directly own.
- Weak link to the broader analog and RF semis complex. Peers moving on end-market data will not move QRVO unless the move passes through Skyworks first.
- Merger-arb flow risk. A crowded arb book delevering as in the January 2026 episode when QRVO fell 7.5% on spread-blowout and thin liquidity can force moves unrelated to deal news.
- China policy tape. Any escalation in US–China semiconductor restrictions raises perceived SAMR risk and widens the spread independent of either company's fundamentals.
Notes
- Merger-arb instrument, not a momentum name 52w-high/RSI/clustered-PT signals are SWKS/arb artifacts; do not treat rule-engine momentum flags as an accelerating QRVO story.
- Deal: SWKS buys QRVO for $32.50 cash + 0.960 SWKS/sh (announced 2025-10-27). ~72% of value is SWKS equity, ~33% cash floor.
- Both shareholder votes cleared 2026-02-11 (SWKS issuance 120.98M for vs 0.29M against). Taiwan TFTC approved 2026-05-13. China SAMR in Phase II the last gate.
- Close timing: formal guidance early-2027, management 'increasingly hopeful' late-2026. Watch SAMR headlines, not the QRVO chart.
- Standalone backstop: Q4 FY26 (2026-05-05) Adj EPS $1.69 vs $1.21, rev $808.3M vs $800.6M; FY27 guide EPS $7.00 vs $6.60. Deal-break floor ~$75-85.
- SWKS fiscal Q3 FY26 earnings ~early Aug 2026 is the next scheduled re-rate of the SWKS leg (drives QRVO by construction).
- Merger-arb instrument, not a momentum name 52w-high / RSI / clustered-PT prints are SWKS and arb artifacts; do not read rule-engine momentum flags as an accelerating QRVO story.
- Deal: SWKS buys QRVO for $32.50 cash + 0.960 SWKS/sh (announced 2025-10-27). ~68% of value is SWKS equity, ~32% cash floor; headline ~$10.1B, combined entity ~$22B, $500M+ synergy target.
- Gates: both shareholder votes cleared 2026-02-11 (issuance 120,980,973 for vs 289,580 against). Taiwan TFTC approved 2026-05-13. China SAMR is the LAST gate, in Phase II with no scheduled decision date.
- Spread watch: gross spread widened from ~5% (early June) to ~9% (June 26) as QRVO fell ~4.5% w/w while SWKS stayed flat arb desks pricing more deal/timing risk, not less.
- Standalone backstop: Q4 FY26 (2026-05-05) Adj EPS $1.69 vs $1.21, rev $808.3M vs $800.6M; FY27 guide EPS $7.00 vs $6.60. Deal-break floor ~$75-85 (52w low $74.92).
- Next scheduled SWKS re-rate = fiscal Q3 FY26 earnings 2026-08-05 (drives QRVO by construction). QRVO fiscal Q1 FY27 ~early Aug. Both just beyond the 30-day window.
- Wolfe downgraded QRVO ~April 2026 citing the pending acquisition; consensus median PT ~$85 sits below the quote only the deal supports price. RBC raised SWKS PT to $80 (Sector Perform) late June.
- Merger-arb instrument, not a momentum name 52w-high / RSI / clustered-PT prints are SWKS and arb artifacts via the 0.960 ratio; do not read rule-engine momentum flags as an accelerating QRVO story.
- Deal (announced 2025-10-27): SWKS buys QRVO for $32.50 cash + 0.960 SWKS/sh. ~33% cash floor, ~67% SWKS equity; headline ~$10.1B, combined entity ~$22B, $500M+ synergy target.
- Gates: both shareholder votes cleared 2026-02-11 (issuance 120,980,973 for vs 289,580 against). Taiwan TFTC approved 2026-05-13. China SAMR is the LAST gate Phase II, no scheduled decision date.
- Close timing: formal guidance early calendar 2027; management 'increasingly hopeful' late-2026. Trade on SAMR headlines, not the chart.
- Standalone backstop: Q4 FY26 (2026-05-05) Adj EPS $1.69 vs $1.21, rev $808.3M vs $800.6M; FY27 guide EPS $7.00 vs $6.60. Deal-break floor ~$75–85, 52w low $74.92.
- Next scheduled SWKS re-rate = fiscal Q3 FY26 earnings ~2026-08-05 (drives QRVO by the 0.960 ratio). QRVO fiscal Q1 FY27 ~early Aug both just inside the 30-day window.
- Wolfe Research downgraded QRVO ~April 2026 on the pending acquisition; consensus median PT ~$85, below the deal-anchored quote only the arb supports the price.
- Deal terms unchanged: SWKS buys QRVO for $32.50 cash + 0.960 SWKS/sh (announced 2025-10-27). Implied value = 32.50 + 0.960 x SWKS recompute every session, the ceiling moves daily.
- MATERIAL CHANGE July 2026: SWKS fell ~25% in 30d to ~$57.50 on Apple dual-sourcing the next iPhone RF component (~20-25% content cut, >$380M mobile revenue). Downgrades: B.Riley Neutral PT $65, Stifel Hold PT $62, Mizuho Neutral PT $62; Morningstar FV $95 -> $70.
- Spread compressed from ~9% (late June) to ~2.6% (2026-07-17) because deal value FELL to meet price, not because price rallied. Reward for the SAMR gate is now single-digit annualized.
- Gates: both shareholder votes cleared 2026-02-11 (issuance 120,980,973 for vs 289,580 against). Taiwan TFTC approved 2026-05-13. China SAMR is the LAST gate, Phase II, no statutory decision deadline.
- Qorvo has DISCONTINUED conference calls and forward guidance for the duration of the deal the 2026-07-28 Q1 FY27 print is a numbers-only release with no management commentary.
- Both QRVO (fiscal Q1 FY27) and SWKS (fiscal Q3 FY26) report 2026-07-28. The SWKS print matters more: ~63% of consideration is SWKS equity and FY27 Apple content guidance refreshes there.
- Standalone backstop: Q4 FY26 (2026-05-05) Adj EPS $1.69 vs $1.21, rev $808.3M vs $800.6M; prior FY27 framework EPS ~$7.00 vs $6.60 consensus. Estimated deal-break floor $75-78, 52w low $74.93.
- Consensus 2026-07-16: Hold, 11 analysts, median PT $91.46 — above current implied deal value of ~$87.7, i.e. the street target embeds a SWKS recovery.
- Prior invalidation level of $84 was calibrated to a ~$102 deal value and is stale; recalibrated to $80 after the SWKS derate.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But the stock just reversed ~16% off its $128.45 ATH; the ~2026-08-10 Q4/full-year print is the next binary.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
SIMO
Silicon Motion Technology Corporation
NAND-controller toll-booth on the steepest flash shortage in ~15 years: TrendForce H1 2026 contract +>100% cumulative, H2 still rising with no capacity adds. Q1 record +105% YoY, sell-side chasing to $400/$450. Fundamental leg ACCELERATING, but the tape is digesting a 4x into insider selling the 2026-07-29 Q2 print is the next binary.
XPO
XPO, Inc.
Freight-cycle upturn is the accelerating narrative: LTL volume and contract pricing re-accelerating after a multi-year trucking recession, with SAIA May tonnage +8.4% confirming the cluster. XPO layers operating-ratio self-help (Q1 LTL OR 83.9%, -200bps YoY) on top. The 2026-07-30 Q2 print is the binary that validates or breaks the "comfortably ahead" yield guide.
See also · stocks to watch